Project Grant 2036119
Award Date
2/1/21
Completion Date
10/31/22
Dollars Obligated
$256K
Federal Agency
National Science Foundation
Awardee
Progenitor Inc. (E24UJ9SLGDK4)
Federal Grant Program
47.084
Assistance Type
Project Grant
Place of Performance
Emigration Canyon, UT 84108, USA
Similar Awards
This Cooperative Agreement award from the National Science Foundation (CFDA 47.084 - NSF Technology, Innovation, and Partnerships program) provides $1,250,000.00 in funding to Rattan Life Science Inc., a small disadvantaged business, to develop a novel platform technology for scalable production of high-quality, tumor-targeted induced naïve T cells for off-the-shelf cancer immunotherapies. The project aims to demonstrate the in vivo anti-tumor efficacy of these induced naïve T cells against...
This $305,000 Small Business Innovation Research (SBIR) Phase I project, awarded by the National Science Foundation (NSF) under its Technology, Innovation, and Partnerships (CFDA 47.084) program, aims to develop a microchip-based technology that uses sound waves and electric fields to manipulate cells and sequentially deliver customizable genetic materials. The goal is to make advanced cell engineering more accessible and enable a wider range of users to perform complex cellular modifications...
This SBIR Phase I award from the National Science Foundation (NSF) under the NSF Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) provides $305,000 to Junipero Therapeutics, Inc. to develop an innovative gene therapy platform. The project aims to create a new class of gene therapies that can be delivered more safely, cost-effectively, and at scale for a wide range of serious genetic disorders, initially focusing on neurodegenerative conditions such as Huntington's disease and...
This SBIR Phase I project, awarded by the National Science Foundation (NSF) under the NSF Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084), aims to develop a method to turn on cancer immunotherapies only at the site of disease. The $275,000 award will support Synsorybio, Inc., a for-profit organization, in creating protein switches that activate immunotherapies in response to disease signals, rather than indiscriminately throughout the body. This approach seeks to improve the...
Rattan Life Science Inc. received a $275,000 Project Grant award from the National Science Foundation under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084) to develop a platform for generating induced pluripotent stem cell-derived naïve CD4+ and CD8+ T cells with fidelity, reproducibility and scalability. The platform employs proprietary induced thymic epithelial cells to provide biologically relevant thymic positive selection signals during T cell differentiation,...
This Project Grant award from the National Science Foundation (NSF) under its Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) provides $275,000 to Tectaria Bio LLC to engineer cell lines with activated proteasomes for increased biomanufacturing efficiency. The project aims to test the feasibility and application of a novel technology to significantly increase the protein production capabilities of cell lines used in the manufacture of biologics, gene therapies, and vaccines....
This is a Project Grant award from the National Science Foundation's (NSF) Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) to Core Biotherapeutics Inc., a small business in Ladera Ranch, CA. The $303,864 award, effective April 1, 2025 through March 31, 2026, supports the development of a platform to identify molecular network drivers of diseases and program them into an algorithm for drug target discovery. The goal is to create a scalable, network-based approach to develop...
This SBIR Phase I award from the National Science Foundation (NSF) under the NSF Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) provides $273,550 to Biocognon LLC for the development of a combinatorial platform to discover improved molecular recognition components for use in therapeutic and diagnostic antibodies. The project aims to utilize synthetic biology, next-generation DNA sequencing, and computational biology to efficiently generate and screen libraries of antibody...
The National Science Foundation awarded Ireprogram, LLC a $256,000 Project Grant under the Small Business Technology Transfer (STTR) program. The grant supports an STTR Phase I project to develop autologous hematopoietic stem cell production techniques to treat graft-versus-host disease. The STTR program seeks small business innovation research and development through public-private partnerships. This award will allow Ireprogram to research stem cell therapies with the goal of ending this...
Neyroblastgx LLC was awarded a $255,997 Project Grant from the National Science Foundation under the NSF Technology, Innovation, and Partnerships program. The grant will support the company's research efforts to genetically engineer dendritic cells to activate T cells specific to the SARS-CoV-2 spike protein, with the goal of developing a novel approach to treating COVID-19. The research is expected to be conducted between April 2021 and December 2022. The NSF Technology, Innovation, and...